Dealing with the Pennsylvania Supreme Court’s Non-Decision on Standards Compliance Evidence
Drug & Device Law
JANUARY 15, 2024
We have discussed how exclusion of FDA compliance in pelvic mesh cases, based on a false equivalence between preemption and evidentiary admissibility, has hampered the defense in that litigation. We haven’t seen standards compliance litigated, but T.M. Janssen Pharmaceuticals, Inc. , 3d 1245 (N.J. Sanchez , 716 A.2d
52 
Let's personalize your content